相关产品推荐更多 >

CD68抗体 | Recombinant Anti-CD68 Monoclonal Antibody
询价
CCAR1抗体 | Anti-CCAR1 Polyclonal Antibody
询价
CD147/Basigin/EMMPRIN (APC)抗体 | Recombinant Anti-CD147/Basigin/EMMPRIN Monoclonal Antibody (APC)
询价
Carbonic Anhydrase XIV/CA14抗体 | Anti-Carbonic Anhydrase XIV/CA14 Polyclonal Antibody
询价
抗PKA 2 beta单抗 | Anti-PKA 2 beta Monoclonal Antibody
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Human Poliovirus Receptor protein
- 形态:
liquid
- 克隆性:
单克隆
- 保质期:
见COA
- 库存:
大量
- 供应商:
北京辰辉创聚生物技术有限公司
- 应用范围:
WB
- 靶点:
Poliovirus Receptor
- 抗体英文名:
Anti-Poliovirus Receptor Monoclonal Antibody
- 抗体名:
抗Poliovirus Receptor单抗
- 规格:
100ul; 500ul; 1ml

| 产品信息
品名:NebuSelect™ Anti-Poliovirus Receptor Monoclonal Antibody
别名:CD155, HVED, mE4, Necl5, PVR, PVS, Taa1, TAGE4
货号:NBAB-193961
品牌:Nebulabio
规格:100ul; 500ul; 1ml
| 产品描述
NebuSelect™ Anti-Poliovirus Receptor Monoclonal Antibody (Cat# NBAB-193961) was produced in rabbits immunized with recombinant Human Poliovirus Receptor protein, and it reacts with Human. This antibody is validated for WB.
| 产品属性
Product Category:Rabbit MAb
Reactivity:Human
Specificity:Human Poliovirus Receptor
Immunogen:Recombinant Human Poliovirus Receptor protein
Isotype:Monoclonal Rabbit IgG
Purification:Protein A & Protein G Affinity Purification
Buffer:0.2 μm filtered solution in PBS, pH7.4, containing 0.09% Sodium azide, 50% glycerol.
Conjugate:Unconjugated
Applications:WB
Dilution:WB: 1:1000~1:5000
Storage:This liquid antibody can be stored at 2℃-8℃ for at least two weeks. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20℃. When reconstituted in sterile pH 7.4 0.01M PBS or antibody diluent, the antibody is stable for at least two weeks at 2-4℃.
For Research Use Only!
To get more information, please contact us freely.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Aspects of CNS Lupus: Mouse Models of Anti-NMDA Receptor Antibody Mediated Reactivity
concepts of these models and provide protocols for the following: (1) the induction of anti-dsDNA, anti-NMDAR antibodies, (2) testing serum antibody titer by ELISA, (3) breaching blood brain barrier (BBB) integrity with LPS and epinephrine, (4) passive
【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
Antibody-Mediated Delivery of siRNAs for Anti-HIV Therapy
, there has been significant progress towards developing reagents that selectively deliver exogenous siRNA to immune cells that are targeted by HIV or involved in viral pathogenesis, such as T cells, macrophages, and dendritic cells. Here, we describe details of two antibody
技术资料暂无技术资料 索取技术资料




